Selected discovery partnerships

We form selected collaborations with biotechnology and pharmaceutical companies where ConfoSeq can unlock differentiated chemistry or create a superior therapeutic profile.

These partnerships combine Illum’s state-resolved discovery platform with complementary disease biology, chemistry and development capabilities to create valuable drug assets.